These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 26684763)

  • 1. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection.
    Kestle JR; Holubkov R; Douglas Cochrane D; Kulkarni AV; Limbrick DD; Luerssen TG; Jerry Oakes W; Riva-Cambrin J; Rozzelle C; Simon TD; Walker ML; Wellons JC; Browd SR; Drake JM; Shannon CN; Tamber MS; Whitehead WE;
    J Neurosurg Pediatr; 2016 Apr; 17(4):391-6. PubMed ID: 26684763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus.
    Edwards NC; Engelhart L; Casamento EM; McGirt MJ
    J Neurosurg; 2015 Jan; 122(1):139-47. PubMed ID: 25380105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Hydrocephalus Clinical Research Network quality improvement initiative: the role of antibiotic-impregnated catheters and vancomycin wound irrigation.
    Chu J; Jensen H; Holubkov R; Krieger MD; Kulkarni AV; Riva-Cambrin J; Rozzelle CJ; Limbrick DD; Wellons JC; Browd SR; Whitehead WE; Pollack IF; Simon TD; Tamber MS; Hauptman JS; Pindrik J; Naftel RP; McDonald PJ; Hankinson TC; Jackson EM; Rocque BG; Reeder R; Drake JM; Kestle JRW; ;
    J Neurosurg Pediatr; 2022 Jun; 29(6):711-718. PubMed ID: 35303708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection rates during eras of intrathecal antibiotic use followed by antibiotic-impregnated catheter use in prevention of cerebrospinal fluid shunt infection.
    Simon TD; Hayati Rezvan P; Coffin SE; Hall M; Hauptman JS; Kronman MP; Mangano FT; Podkovik S; Pollack IF; Schaffzin JK; Thorell E; Warf BC; Zhou C; Whitlock KB
    J Neurosurg Pediatr; 2024 Oct; 34(4):357-364. PubMed ID: 39029119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.
    Konstantelias AA; Vardakas KZ; Polyzos KA; Tansarli GS; Falagas ME
    J Neurosurg; 2015 May; 122(5):1096-112. PubMed ID: 25768831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A standardized protocol to reduce cerebrospinal fluid shunt infection: the Hydrocephalus Clinical Research Network Quality Improvement Initiative.
    Kestle JR; Riva-Cambrin J; Wellons JC; Kulkarni AV; Whitehead WE; Walker ML; Oakes WJ; Drake JM; Luerssen TG; Simon TD; Holubkov R;
    J Neurosurg Pediatr; 2011 Jul; 8(1):22-9. PubMed ID: 21721884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shunting outcomes in posthemorrhagic hydrocephalus: results of a Hydrocephalus Clinical Research Network prospective cohort study.
    Wellons JC; Shannon CN; Holubkov R; Riva-Cambrin J; Kulkarni AV; Limbrick DD; Whitehead W; Browd S; Rozzelle C; Simon TD; Tamber MS; Oakes WJ; Drake J; Luerssen TG; Kestle J;
    J Neurosurg Pediatr; 2017 Jul; 20(1):19-29. PubMed ID: 28452657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shunt infection prevention practices in Hydrocephalus Clinical Research Network-Quality: a new quality improvement network for hydrocephalus management.
    Tamber MS; Jensen H; Clawson J; Nunn N; Wellons JC; Smith J; Martin JE; Kestle JRW;
    J Neurosurg Pediatr; 2024 Feb; 33(2):157-164. PubMed ID: 38000067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for shunt malfunction in pediatric hydrocephalus: a multicenter prospective cohort study.
    Riva-Cambrin J; Kestle JR; Holubkov R; Butler J; Kulkarni AV; Drake J; Whitehead WE; Wellons JC; Shannon CN; Tamber MS; Limbrick DD; Rozzelle C; Browd SR; Simon TD;
    J Neurosurg Pediatr; 2016 Apr; 17(4):382-90. PubMed ID: 26636251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of rifampicin and clindamycin impregnated devices against Staphylococcus spp. infection after cerebrospinal fluid diversion procedures.
    Gutiérrez-González R; Boto GR; Fernández-Pérez C; del Prado N
    BMC Neurol; 2010 Oct; 10():93. PubMed ID: 20939914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial experience with silver-impregnated polyurethane ventricular catheter for shunting of cerebrospinal fluid in patients with infected hydrocephalus.
    Izci Y; Secer H; Akay C; Gonul E
    Neurol Res; 2009 Apr; 31(3):234-7. PubMed ID: 19040800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems.
    Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
    J Neurosurg; 2015 Feb; 122(2):443-8. PubMed ID: 25415066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antibiotic-impregnated shunt catheters in decreasing the incidence of shunt infection in the treatment of hydrocephalus.
    Sciubba DM; Stuart RM; McGirt MJ; Woodworth GF; Samdani A; Carson B; Jallo GI
    J Neurosurg; 2005 Aug; 103(2 Suppl):131-6. PubMed ID: 16370278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic impregnated catheters and intrathecal antibiotics for CSF shunt infection prevention in children undergoing low-risk CSF shunt surgery.
    Podkovik S; Zhou C; Coffin SE; Hall M; Hauptman JS; Kronman MP; Mangano FT; Pollack IF; Sedano S; Vega J; Schaffzin JK; Thorell E; Warf BC; Whitlock KB; Simon TD
    BMC Pediatr; 2024 May; 24(1):325. PubMed ID: 38734598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the use of antibiotic-impregnated external ventricular drainage beneficial in the management of iatrogenic ventriculitis?
    Soleman J; Marbacher S; Fandino J; Fathi AR
    Acta Neurochir (Wien); 2012 Jan; 154(1):161-4; discussion 164. PubMed ID: 21928119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.
    Simon TD; Kronman MP; Whitlock KB; Gove NE; Mayer-Hamblett N; Browd SR; Cochrane DD; Holubkov R; Kulkarni AV; Langley M; Limbrick DD; Luerssen TG; Oakes WJ; Riva-Cambrin J; Rozzelle C; Shannon C; Tamber M; Wellons JC; Whitehead WE; Kestle JRW
    J Neurosurg Pediatr; 2018 Apr; 21(4):346-358. PubMed ID: 29393813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has the introduction of antibiotic-impregnated external ventricular drain catheters changed the nature of the microorganisms cultured in patients with drain-related infection? A single neurosurgical centre's experience.
    Talibi S; Tarnaris A; Shaw SA
    Br J Neurosurg; 2016 Oct; 30(5):560-6. PubMed ID: 27195449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple protocol to prevent external ventricular drain infections.
    Flint AC; Rao VA; Renda NC; Faigeles BS; Lasman TE; Sheridan W
    Neurosurgery; 2013 Jun; 72(6):993-9; discussion 999. PubMed ID: 23467249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in CSF shunt infection over a 10-year period associated with the application of concentrated topical antibiotic powder directly to surgical wounds prior to closure.
    Beckman JM; Amankwah EK; Tetreault LL; Tuite GF
    J Neurosurg Pediatr; 2015 Dec; 16(6):648-61. PubMed ID: 26382185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal shunt infection in patients receiving antibiotic-impregnated versus standard shunts.
    Parker SL; Anderson WN; Lilienfeld S; Megerian JT; McGirt MJ
    J Neurosurg Pediatr; 2011 Sep; 8(3):259-65. PubMed ID: 21882917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.